Neurocrine Biosciences shares owned by BlackRock
Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by BlackRock
from 13F filings
Historical chart of BlackRock investment in Neurocrine Biosciences
Tip: Access up to 7 years of quarterly data
All positions including Neurocrine Biosciences held by BlackRock consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Neurocrine Biosciences by BlackRock
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $2.0B | 14M | 137.67 |
| 2024-03-31 | $1.9B | 14M | 137.92 |
| 2023-09-30 | $1.5B | 13M | 112.50 |
| 2023-06-30 | $1.3B | 14M | 94.30 |
| 2023-03-31 | $1.4B | 14M | 101.22 |
| 2022-12-31 | $1.5B | 13M | 119.44 |
| 2022-06-30 | $1.2B | 12M | 97.48 |
| 2021-06-30 | $987M | 10M | 97.32 |
| 2021-03-31 | $1.1B | 11M | 97.25 |
| 2020-12-31 | $671M | 7.0M | 95.85 |
| 2020-09-30 | $655M | 6.8M | 96.16 |
| 2020-03-31 | $602M | 7.0M | 86.55 |
| 2019-12-31 | $709M | 6.6M | 107.49 |
| 2019-09-30 | $535M | 5.9M | 90.11 |
| 2019-06-30 | $478M | 5.7M | 84.43 |
| 2019-03-31 | $484M | 5.5M | 88.10 |
| 2018-12-31 | $356M | 5.0M | 71.41 |
| 2018-09-30 | $627M | 5.1M | 122.95 |
| 2018-06-30 | $499M | 5.1M | 98.24 |
| 2018-03-31 | $407M | 4.9M | 82.94 |
| 2017-09-30 | $298M | 4.9M | 61.27 |
| 2016-12-31 | $1.4M | 35k | 38.71 |
| 2016-09-30 | $3.9M | 77k | 50.63 |
| 2016-06-30 | $3.3M | 72k | 45.44 |
| 2016-03-31 | $2.5M | 64k | 39.55 |
| 2015-12-31 | $4.2M | 73k | 56.57 |
| 2015-09-30 | $1.9M | 47k | 39.79 |
| 2015-06-30 | $2.6M | 54k | 47.77 |
| 2015-03-31 | $2.2M | 56k | 39.72 |
| 2014-12-31 | $1.7M | 74k | 22.33 |
| 2014-09-30 | $1.8M | 112k | 15.67 |
| 2014-06-30 | $1.8M | 121k | 14.84 |
| 2014-03-31 | $1.9M | 117k | 16.10 |
| 2013-12-31 | $21k | 2.2k | 9.71 |
| 2013-09-30 | $26k | 2.2k | 11.65 |
| 2013-06-30 | $30k | 2.2k | 13.59 |